A subset of MG patients possess autoantibodies against muscle-specific kinase (MuSK) [2], [3] or its partner protein, low-density lipoprotein receptor-related protein 4 (LRP4) [4], [5], instead of AChR autoantibodies. The gene discussed is LRP4; the disease is myasthenia gravis.